Abnormal expression of OPN is detected in a variety of tumors (breast cancer, prostate cancer, lung cancer, gastric cancer, and melanoma) and is closely associated with the initiation, metastasis, and prognosis of breast cancer [6, 7]. Here, SPP1 is linked to breast cancer.